Search PDMR transactions

Notifier
Name of person with notification obligation
Dag Andersson Tilk
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Dag Andersson Tilk
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Xvivo Perfusion Aktiebolag
Issuer´s LEI code
549300G2464FYLS14B41
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Xvivo Perfusion AB SE0004840718 Acquisition 499 Quantity 199.80 SEK 19/08/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Xvivo Perfusion AB SE0004840718 Acquisition 19/08/2022 NASDAQ STOCKHOLM AB 499 (Quantity) 199.80 SEK
Total: 499
<< Back